Skip to main content
Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.640
-0.050 (-2.96%)
At close: Apr 28, 2026, 4:00 PM EDT
1.700
+0.060 (3.66%)
Pre-market: Apr 29, 2026, 7:49 AM EDT

Neuronetics Revenue

In the year 2025, Neuronetics had annual revenue of $149.16M with 99.17% growth. Neuronetics had revenue of $41.78M in the quarter ending December 31, 2025, with 85.73% growth.

Revenue (ttm)
$149.16M
Revenue Growth
+99.17%
P/S Ratio
0.77
Revenue / Employee
$226,682
Employees
658
Market Cap
114.11M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025149.16M74.27M99.17%
Dec 31, 202474.89M3.54M4.96%
Dec 31, 202371.35M6.14M9.42%
Dec 31, 202265.21M9.89M17.89%
Dec 31, 202155.31M6.07M12.32%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Treace Medical Concepts 212.69M
Quanterix 138.90M
Outset Medical 119.48M
Owlet 105.71M
AVITA Medical 71.61M
Apyx Medical 52.84M
SANUWAVE Health 44.05M
Rapid Micro Biosystems 33.59M
Revenue Rankings

STIM News

More News